Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 25% ± 9% | |
astrocyte | 7 studies | 28% ± 12% | |
epithelial cell | 6 studies | 30% ± 9% | |
ciliated cell | 6 studies | 22% ± 5% | |
interneuron | 5 studies | 34% ± 18% | |
endothelial cell of lymphatic vessel | 5 studies | 19% ± 2% | |
GABAergic neuron | 5 studies | 33% ± 7% | |
neuron | 4 studies | 26% ± 4% | |
glutamatergic neuron | 4 studies | 35% ± 7% | |
oligodendrocyte | 4 studies | 21% ± 3% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 5% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
fibroblast | 3 studies | 19% ± 3% | |
erythroblast | 3 studies | 27% ± 7% | |
dendritic cell | 3 studies | 27% ± 8% | |
basal cell | 3 studies | 31% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 991.67 | 21 / 21 | 100% | 5.99 | 504 / 504 |
breast | 100% | 1031.46 | 459 / 459 | 100% | 4.17 | 1118 / 1118 |
esophagus | 100% | 1025.81 | 1445 / 1445 | 100% | 4.03 | 183 / 183 |
intestine | 100% | 1064.06 | 966 / 966 | 100% | 6.23 | 527 / 527 |
lung | 100% | 859.80 | 578 / 578 | 100% | 4.48 | 1155 / 1155 |
pancreas | 100% | 932.49 | 328 / 328 | 100% | 4.37 | 178 / 178 |
prostate | 100% | 1332.83 | 245 / 245 | 100% | 6.23 | 502 / 502 |
thymus | 100% | 1421.01 | 653 / 653 | 100% | 5.23 | 605 / 605 |
uterus | 100% | 1153.92 | 170 / 170 | 100% | 5.22 | 459 / 459 |
skin | 100% | 1124.60 | 1809 / 1809 | 100% | 6.70 | 471 / 472 |
ovary | 100% | 1153.62 | 180 / 180 | 100% | 4.49 | 429 / 430 |
liver | 100% | 657.48 | 226 / 226 | 100% | 4.21 | 405 / 406 |
kidney | 100% | 1052.70 | 89 / 89 | 100% | 3.44 | 898 / 901 |
stomach | 100% | 860.23 | 359 / 359 | 100% | 5.62 | 285 / 286 |
adrenal gland | 100% | 802.62 | 258 / 258 | 100% | 4.71 | 229 / 230 |
brain | 99% | 849.32 | 2625 / 2642 | 100% | 3.84 | 705 / 705 |
adipose | 100% | 905.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 4.55 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.66 | 29 / 29 |
spleen | 100% | 930.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.68 | 1 / 1 |
blood vessel | 100% | 748.19 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 808.01 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 426.71 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 388.68 | 569 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043248 | Biological process | proteasome assembly |
GO_0032991 | Cellular component | protein-containing complex |
GO_0044877 | Molecular function | protein-containing complex binding |
Gene name | PSMG4 |
Protein name | Proteasome assembly chaperone 4 (PAC-4) (hPAC4) Proteasome assembly chaperone 4 |
Synonyms | C6orf86 PAC4 |
Description | FUNCTION: Chaperone protein which promotes assembly of the 20S proteasome. . |
Accessions | Q5JS54 ENST00000451246.2 ENST00000454610.2 ENST00000419065.6 [Q5JS54-2] ENST00000473000.2 [Q5JS54-3] D6R926 ENST00000438998.7 [Q5JS54-1] ENST00000380306.8 D6REN3 ENST00000324987.4 ENST00000380305.4 H7C465 F2Z3E0 ENST00000509933.1 D6RB92 E2QRC7 |